Eicosapentaenoic acid and chemoprevention of FAP.
Lynch
Patrick M
PM
Department of Gastroenterology, Hepatology & Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA. plynch@mdanderson.org
D011125:Adenomatous Polyposis Coli / Q000517:prevention & control*; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D006801:Humans
D016588:Anticarcinogenic Agents; D052246:Cyclooxygenase 2 Inhibitors; D015118:Eicosapentaenoic Acid